Drawing for LEUCOSACCHARIDE

USPTO serial 99355497

LEUCOSACCHARIDE

Reviewed by CopyMark Law Group

Status 681
Filing date
Status date
Registration date
—
Examiner
BURKE, KELLY CHRISTINE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with LEUCOSACCHARIDE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kumiko Ide

Kumiko Ide WENDEROTH, LIND & PONACK, LLP1025 Connecticut Avenue NW, Suite 500Washington, DC 20036United States

Goods and services

ClassDescriptionStatusFirst use
001Lactic acid bacteria powder for use in the manufacture of food, dietary supplements for humans or beverages; other microorganism, namely, bacteria and bacteria powder for use in the manufacture of food, dietary supplements for humans or beverages; polysaccharides for use in the manufacture of food, dietary supplements for humans or beverages; chemical products for the fresh-keeping and preserving of food; glue and adhesives for industrial purposes; plant growth regulating preparations; fertilizers; higher fatty acids for industrial purposes; unprocessed plastics; gluten for the food industryACTIVE—
003Cosmetics; cosmetic soaps and detergents for household use; dentifrices; perfume and flavour materials, namely, food flavorings prepared from essential oils or polysaccharide sold as an integral component of essential oils derived from microorganisms; false nails; false eyelashes; breath freshening preparations for personal hygiene; deodorants for animals; incenseACTIVE—
005Pharmaceutical preparations other than for agricultural purposes for the treatment and prevention of metabolic and endocrine diseases, namely, diabetes, diabetic complication, hyperlipidemia, hyperuricemia, gout, lifestyle related disease, nutritional disorders, impaired glucose tolerance, metabolic syndrome, obesity and lipid disorder, cardiovascular, urological and reproductive diseases, namely, hypertension, hyperglycemia, ischemic heart disease, hyperinsulinemia, arteriosclerosis, myocardial infarction, angina pectoris, aneurysm, chronic kidney disease, renal calculi, kidney disease, pyelonephritis, nephritis, urethritis, cystitis, hypercholesterolemia and high triglyceridemia, respiratory diseases, namely, bronchitis, pulmonary emphysema and lung inflammation, digestive and oral diseases, namely, abnormality of the intestinal flora, abdominal distension, peptic ulcer, intestinal disease, inflammatory disorder, irritable bowel syndrome, gastric ulcer, inflammatory bowel disease, Crohn's disease, diverticulitis, liver cirrhosis, fatty liver, diarrhea, constipation, loose stool disease, hepatic inflammation, non-alcoholic steatohepatitis, viral hepatitis, alcoholic hepatitis, dental disease, periodontal diseases, stomatitis, xerostomia and cyst, immune, inflammatory and allergic diseases, namely, immune related diseases and abnormalities, type I, II, III, IV and V allergy, pollinosis, atopic dermatitis, psoriasis, autoimmune disease and connective tissue disease, bone and articular diseases, namely, rheumatism, osteoporosis and articular inflammation, pathogenic microbial and malignant neoplastic diseases, namely, infection, cancer and malignant tumor, mental and nervous system diseases, namely, mental disorder, dementia, Alzheimer's disease, bipolar disorder, depression, anorexia, insomnia, cerebral apoplexy, cerebral infarction, autism, neuroinflammation, overwork related disease and nerve inflammation related diseases and cancers resulting from chronic inflammation, and sensory system and skin diseases, namely, ophthalmic disease, ocular inflammation, otorhinolaryngology disease and skin inflammation; pharmaceutical preparations in the nature of medicines for dental purposes; reagent paper for medical purposes; oiled paper for medical purposes; drug delivery agents in the form of edible wrapping wafers for wrapping of powdered medicine doses; gauze for dressings; empty capsules for pharmaceuticals; eyepatches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton for medical purposes; adhesive plasters for medical purposes; bandages for dressings; antiseptic liquid bandages; breast-nursing pads; cotton swabs for medical use; dental materials, namely, dental adhesives; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic food adapted for medical purposes; beverages for babies, namely, infant formula; food for babies; dietary supplements for animalsACTIVE—
016Paper and cardboard; printed matter, namely, paper signs, books, manuals, curricula, newsletters, informational cards and brochures in the field of healthACTIVE—
029Milk products excluding ice cream, ice milk and frozen yogurt; edible oils and fats; fresh, chilled, or frozen meat for human consumption; fresh, chilled or frozen edible aquatic animals, not live; processed meat products, namely, dried meat and chicken, prepared meat, fish croquettes, sausages, ham, and bacon; processed seafood products other than blocks of boiled, smoked and then dried bonitos, dried pieces of agar jelly, flakes of dried fish meat, fishmeal for human consumption, edible shavings of dried kelp, sheets of dried laver, dried brown alga, dried edible seaweed and toasted sheets of laver, namely, tinned and processed fish; processed vegetables and fruits; protein for use as a food additive, namely, textured vegetable protein for use as a meat extenderACTIVE—
030Tea; coffee roasted, powdered, granulated, or in drinks; cocoa roasted, powdered, granulated, or in drinks; confectionery made of sugar, sugar substitutes derived from microorganism, or sugar substitutes derived from polysaccharide; bread and buns; sandwiches; steamed buns stuffed with minced meat; hamburgers being sandwiches; pizzas; hot dogs being sandwiches; meat pies; cube sugar; fructose for culinary purposes; crystallized sugar for decorating food; sugar; maltose for culinary purposes; honey; glucose for culinary purposes; powdered starch syrup for culinary purposes; starch syrup for culinary purposes; ice cream mixes; sherbet mixes; flourACTIVE—
032Whey beverages; carbonated non-alcoholic drinks being refreshing beverages; fruit juices; vegetable juices being beverages; beer; extracts of hops for making beerACTIVE—
033Awamori being distilled rice spirits; sake substitute, namely, yellow rice wine; Japanese white liquor being shochu; Japanese sweet rice-based mixed liquor being shiro-zake; Sake; Japanese regenerated liquors being naoshi; Japanese shochu-based mixed liquor being mirin; western liquors in general; alcoholic fruit beverages; Japanese shochu-based mixed liquor beverages being chuhai; Chinese liquors in general; flavored liquorsACTIVE—
035Advertising and publicity servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 15, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 27, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 27, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 27, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 27, 2026XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Apr 27, 2026XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Jan 27, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 27, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 27, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 14, 2026DOCKASSIGNED TO EXAMINER—
Jan 13, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 25, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 25, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance